Article
Advances in immunotyping of colorectal cancer
9 Oct 2023
Abstract excerpt
Immunotherapy has transformed treatment for various types of malignancy. However, the benefit of immunotherapy is limited to a minority of patients with mismatch-repair-deficient (dMMR) and microsatellite instability-high (MSI-H) (dMMR-MSI-H) colorectal cancer (CRC). Understanding the complexity and heterogeneity of the tumor immune microenvironment (TIME) and identifying immune-related CRC subtypes will improve...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
